论文部分内容阅读
目的:探究银杏达莫注射液治疗脑动脉硬化供血不全的临床疗效。方法:将本院在2014年5月-2015年2月收治的80例慢性脑供血不足患者随机分为观察组和对照组,观察组应用银杏达莫注射液治疗,对照组应用复方丹参注射液治疗,对两组的临床疗效进行对比观察。结果:经过治疗后,实验组患者的治疗总有效率明显高于对照组患者;且实验组患者的血脂、血液流变指标等改善值也明显优于对照组(P﹤0.05)。结论:银杏达莫注射液治疗脑动脉硬化供血不全的效果显著,值得在今后的临床治疗中继续推广使用。
Objective: To investigate the clinical efficacy of Yinxingdamo injection in the treatment of cerebral arteriosclerosis insufficiency. Methods: Eighty patients with chronic cerebral insufficiency admitted to our hospital from May 2014 to February 2015 were randomly divided into observation group and control group. The observation group was treated with Yinxingdamo injection. The control group was treated with compound Danshen injection Treatment, the clinical efficacy of the two groups were observed and compared. Results: After treatment, the total effective rate of the experimental group was significantly higher than that of the control group. The improvement of blood lipid and blood rheology indexes of the experimental group was also significantly better than that of the control group (P <0.05). Conclusion: The effect of Yinxingdamo injection in the treatment of cerebral arteriosclerosis insufficiency is significant, so it is worth to continue to be used in future clinical treatment.